SUN’IY INTELLEKT TEXNOLOGIYALARINING ZAMONAVIY FARMATSEVTIKADA — DORI VOSITALARINI YARATISH VA RIVOJLANTIRISHDAGI TATBIQI
Аннотация
Ushbu maqolada sun’iy intellekt (AI) texnologiyalarining zamonaviy farmatsevtika sohasidagi, xususan yangi dori vositalarini kashf etish, ularni ishlab chiqish, klinik sinovlarni optimallashtirish va shaxsiylashtirilgan davolash strategiyalarini shakllantirishdagi o‘rni tahlil qilingan. 2025–2026-yillarda e’lon qilingan xalqaro ilmiy nashrlar va sohaviy tahliliy hisobotlar asosida AI texnologiyalarining farmatsevtik R&D (tadqiqot va ishlanma) jarayonini qanday tezlashtirayotgani, shu bilan birga tibbiy-huquqiy tartibga solish (regulyatsiya) sohasida yuzaga kelayotgan yangi talablar yoritilgan. Maqolada shuningdek O‘zbekiston farmatsevtika ta’limi va sanoatida ushbu texnologiyalarni joriy etishning istiqbollari, yosh mutaxassislar uchun raqamli ko‘nikmalarning ahamiyati bo‘yicha fikr-mulohazalar keltirilgan.
Ключевые слова:
Библиографические ссылки
Ali T., Alqahtani T., Shmrany H.A. va boshq. Artificial Intelligence in Drug Discovery and Development: Transforming Pharmaceutical Innovation // Drug Development Research, 2026, vol. 87, e70281.
Dey M., Amour A. Applications of Artificial Intelligence in Drug Discovery // Emerging Topics in Life Sciences, 2025.
From Algorithm to Medicine: AI in the Discovery and Development of New Drugs // Pharmaceuticals (MDPI), 2026, vol. 7, no. 1, art. 26.
Serrano D.R., Luciano F.C., Anaya B.J. va boshq. Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine // Pharmaceutics, 2024, vol. 16, no. 10, art. 1328.
AI in Drug Discovery: Predictions for 2026 // Drug Target Review, 2026-yil aprel tahlili.
The Future of AI and Innovation in Pharma in 2026 and Beyond // Eularis, sohaviy tahliliy hisobot, 2025.
Top 20 AI Drug Discovery Companies in 2026 — Ranked by Impact // PharmaNow, sohaviy sharh, 2026.
European Union. Artificial Intelligence Act — High-risk Provisions, kuchga kirish sanasi: 2-avgust, 2026.
U.S. Food and Drug Administration. Draft Guidance on the Use of Artificial Intelligence in Regulatory Decision-Making for Drugs, 2026.
Explainable Artificial Intelligence for Drug Discovery and Development — A Comprehensive Survey // arXiv, 2023 (2026-yilgacha yangilangan tahlillar bilan).
География читателей
Загрузки
Опубликован
Выпуск
Раздел
Лицензия
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Как цитировать
